Document:

<PAGE>
                                                                   EXHIBIT 10.64

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY APPLICABLE STATE
SECURITIES LAW, AND SHALL NOT BE: (1) SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE
TRANSFERRED FOR CONSIDERATION, BY THE HOLDER, EXCEPT UPON THE ISSUANCE TO THE
COMPANY OF AN OPINION OF ITS COUNSEL AND/OR THE SUBMISSION TO THE COMPANY OF
SUCH OTHER EVIDENCE AS MAY BE SATISFACTORY TO COUNSEL FOR THE COMPANY, IN EITHER
CASE TO THE EFFECT THAT ANY SUCH TRANSFER FOR CONSIDERATION SHALL NOT REQUIRE
REGISTRATION UNDER THE ACT <OR RULE 144 PROMULGATED BY THE SECURITIES AND
EXCHANGE COMMISSION> UNDER THE ACT AND APPLICABLE STATE SECURITIES LAW; OR (2)
TRANSFERRED WITHOUT CONSIDERATION BY THE HOLDER EXCEPT UPON THE ISSUANCE TO THE
COMPANY OF AN OPINION OF ITS COUNSEL OR THE SUBMISSION TO THE COMPANY OF SUCH
OTHER EVIDENCE AS MAY BE SATISFACTORY TO COUNSEL TO THE COMPANY, IN EITHER CASE
TO THE EFFECT THAT ANY SUCH TRANSFER SHALL NOT REQUIRE REGISTRATION UNDER THE
ACT AND APPLICABLE STATE SECURITIES LAW.

                                     WARRANT

Date of Issuance: March 18, 2002                  Certificate No. W-____________

         FOR VALUE RECEIVED, Horizon Medical Products, Inc., a Georgia
corporation (the "Company"), hereby grants to Cardinal Investment Fund I LLC, as
assignee of Standard Federal Bank, National Association, acting by and through
LaSalle Business Credit, Inc., as its agent (the "Registered Holder") the right
to purchase from the Company the number of shares of the Common Stock of the
Company ("Exercise Shares") equal to nine tenths of a percent (.9%) of the
Company's Common Stock outstanding at the Exercise Time on a Fully Diluted Basis
at a per share purchase price of $0.01 (the "Exercise Price"). The amount and
kind of securities purchasable pursuant to the rights granted hereunder and the
purchase price for such securities are subject to adjustment pursuant to the
provisions contained in this Warrant.

         All capitalized terms used in this Warrant, unless otherwise defined
herein, shall have the meaning ascribed to such terms in the Loan Agreement (as
defined in Section 6 hereof) and such definitions shall survive any termination
of the Loan Agreement.

         This Warrant is subject to the following provisions:

         Section 1.   Exercise of Warrant.

                  1A. Exercise Period. The Registered Holder may exercise, in
whole or in part (but not as to a fractional share of Common Stock), the
purchase rights represented by this Warrant at any time and from time to time
after the date hereof; provided, however, that this Warrant shall expire to the
extent then unexercised as of 5:00 p.m., prevailing eastern time, on March 18,
2012 (the "Exercise Period"). The Company shall give the Registered Holder
written notice of the termination of the Exercise Period at least 30 days but
not more than 90 days prior to the end of the Exercise Period.

<PAGE>

                  1B.      Exercise Procedure.

                  (i) The right to acquire Common Stock represented by this
Warrant will be deemed to have been exercised when the Company has received all
of the following items (the "Exercise Time"):

                           (a) a completed Exercise Agreement, as described in
                  paragraph 1C below and set forth hereto as Exhibit A, executed
                  by the Person exercising all or part of the purchase rights
                  represented by this Warrant (the "Purchaser") below;

                           (b)      this Warrant;

                           (c) if this Warrant is not registered in the name of
                  the Purchaser, an Assignment or Assignments in the form set
                  forth in Exhibit B hereto evidencing the assignment of this
                  Warrant to the Purchaser, in which case the Registered Holder
                  will have complied with the provisions set forth in Section 8
                  hereof;

                           (d) a check payable to the Company, or a wire
                  transfer of immediately available funds to an account
                  specified by the Company, in an amount equal to the product of
                  the Exercise Price multiplied by the number of shares of
                  Common Stock purchased upon such exercise (the "Aggregate
                  Exercise Price"); provided, however, that the Registered
                  Holder may exercise this Warrant in whole or in part by the
                  surrender of this Warrant to the Company, with a duly executed
                  Exercise Agreement marked to reflect "Net Issue Exercise" and
                  specifying the number of shares of Common Stock to be
                  purchased and upon such Net Issue Exercise, the Registered
                  Holder shall be entitled to pay the exercise price for Common
                  Stock to be purchased hereunder, valued at Fair Market Value
                  less the Exercise Price thereof.

                  (ii) Certificates representing Common Stock purchased upon
exercise of any portion of this Warrant will be delivered by the Company to the
Purchaser within five (5) business days after the Exercise Time. Unless this
Warrant has expired or all of the purchase rights represented hereby have been
exercised, the Company will prepare a new Warrant, substantially identical
hereto, representing the rights formerly represented by this Warrant which have
not expired or been exercised and will deliver such new Warrant at the Exercise
Time to the Person designated for delivery in the Exercise Agreement.

                  (iii) Common Stock issuable upon the exercise of this Warrant
will be deemed to have been issued to the Purchaser at the Exercise Time, and
the Purchaser will be deemed for all purposes to have become the record holder
of such Common Stock at the Exercise Time.

                  (iv) The issuance of certificate(s) representing Common Stock
upon exercise of this Warrant will be made without charge to the Purchaser for
any issuance tax in respect thereof or other cost incurred by the Company in
connection with such exercise and the related issuance of Common Stock.

                  (v) The Company will not close its books against the transfer
of this Warrant or any Common Stock issued or issuable upon the exercise of this
Warrant in any manner which interferes with the timely exercise of this Warrant.
The Company will from time to time take all such action as may be necessary to
assure that the par value per share of the unissued Common Stock acquirable upon
exercise of this Warrant is at all times equal to or less than the Exercise
Price then in effect.

                                       -2
<PAGE>

                  (vi) The Company shall assist and cooperate with any Purchaser
required to make any governmental filings or obtain any governmental approvals
prior to or in connection with any exercise of this Warrant (including, without
limitation, making any filings required to be made by the Company).

                  (vii) The Company shall at all times reserve and keep
available out of its authorized but unissued shares of Common Stock solely for
the purpose of issuance upon the exercise of this Warrant, such number of shares
of Common Stock issuable upon the exercise of this Warrant and all other
outstanding warrants. All Common Stock which is so issuable shall, when issued,
be duly and validly issued and, upon payment of the Exercise Price therefor,
shall be fully paid and nonassessable and free from all taxes, liens and
charges. The Company shall take all such actions as may be reasonably necessary
to assure that all such Common Stock may be so issued without violation of any
applicable law or governmental regulation or any requirements of any domestic
securities exchange upon which Common Stock is listed (except for official
notice of issuance which shall be immediately delivered by the Company upon each
such issuance).

                  1C. Exercise Agreement. Upon any exercise of this Warrant, the
Exercise Agreement will be substantially in the form set forth in Exhibit A
hereto, except that if the Common Stock is not to be issued in the name of the
Person in whose name this Warrant is registered, the Exercise Agreement will
also state the name of the Person to whom the certificates for the Common Stock
are to be issued, and if the number of shares of Common Stock to be issued does
not include all of the Common Stock purchasable hereunder, it will also state
the name of the Person to whom a new Warrant for the unexercised portion of the
rights hereunder is to be delivered. Such Exercise Agreement will be dated the
actual date of execution thereof.

                  1D. Fractional Shares. If a fractional share of Common Stock
would, but for the provisions of paragraph 1A, be issuable upon exercise of the
rights represented by this Warrant, the Company will, within five Business Days
after the date of the Exercise Time, deliver to the Purchaser a check payable to
the Purchaser in lieu of such fractional share in an amount equal to the Current
Market Value of such fractional share as of the date of the Exercise Time.

         Section 2. Adjustment of Number of Exercise Shares. In order to prevent
dilution of the rights granted under this Warrant, the number of Exercise Shares
obtainable upon exercise of this Warrant shall be subject to adjustment from
time to time as provided in this Section 2.

                  2A. Subdivision or Combination of Common Stock. If the Company
at any time subdivides (by any stock split, stock dividend, recapitalization or
otherwise) one or more classes of its outstanding shares of Common Stock into a
greater number of shares, the Exercise Price in effect immediately prior to such
subdivision shall be proportionately decreased and the number of shares of
Common Stock issuable upon exercise of this Warrant will be proportionately
increased. If the Company at any time combines (by reverse stock split or
otherwise) one or more classes of its outstanding shares of Common Stock into a
smaller number of shares, the Exercise Price in effect immediately prior to such
combination shall be proportionately increased and the number of shares of
Common Stock obtainable upon exercise of this Warrant will be proportionately
decreased.

                  2B. Reorganization, Reclassification, Consolidation, Merger or
Sale. Any recapitalization, reorganization, reclassification, consolidation,
merger, sale of all or substantially all of the Company's assets or other
transaction which is effected in such a way that holders of Common Stock are
entitled to receive (either directly or upon subsequent liquidation) stock,
securities, cash or other assets with respect to or in exchange for Common Stock
is referred to herein as an "Organic Change." Prior to the consummation of any
Organic Change, the Company will make appropriate provision (in form and
substance satisfactory to the Registered Holder of this Warrant) to insure that
the Registered Holder of this Warrant shall thereafter have the right to

                                      -3-

<PAGE>

acquire and receive, in lieu of or addition to (as the case may be), the number
of shares of Common Stock immediately theretofore acquirable and receivable upon
the exercise of such holder's Warrant, such shares of stock, securities, cash or
other assets as may be issued or payable with respect to or in exchange for the
number of shares of Common Stock immediately theretofore acquirable and
receivable upon exercise of such holder's Warrant had such Organic Change not
taken place. In any such case, the Company will make appropriate provision (in
form and substance satisfactory to the Registered Holder of this Warrant) with
respect to such holders' rights and interests to insure that provisions of this
Section 2 and Sections 3 and 4 hereof will thereafter be applicable to the
Warrants. The Company will not effect any such Organic Change, unless prior to
the consummation thereof, the successor entity (if other than the Company)
resulting from consolidation or merger or the corporation purchasing such assets
assumes by written instrument (in form and substance satisfactory to the
Registered Holder of this Warrant), the obligation to deliver to such holder
such shares of stock, securities, cash or other assets as, in accordance with
the foregoing provisions, such holder may be entitled to acquire.

                  2C. Adjustment of Number of Exercise Shares upon Issuance of
Shares of Common Stock or Stock Equivalents. If and whenever an or after the
Closing Date, the Company issues or sells, or in accordance with paragraph 2D is
deemed to have issued or sold, any shares of Common Stock for a consideration
per share of Common Stock less than the Fair Market Value per share of Common
Stock at the time of such issue or sale (not including the issuance of shares of
Common Stock pursuant to exercise of this Warrant), then upon such issue or
sale, the Exercise Shares will be increased by multiplying such number by a
fraction, (A) the numerator of which is the Fair Market Value per share of
Common Stock at the time of such issue or sale and (B) the denominator of which
is the amount determined by dividing (a) the sum of (1) the product derived by
multiplying the Fair Market Value per share of Common Stock at the time of such
issue or sale times the number of shares of Common Stock outstanding on a Fully
Diluted Basis immediately prior to such issue or sale, plus (2) the aggregate
consideration, if any, received by the Company upon such issue or sale, by (b)
the number of shares of Common Stock outstanding on a Fully Diluted Basis
immediately after such issue or sale.

                  2D. Effect on Exercise Shares of Certain Events.  For
purposes of determining the adjusted Exercise Shares of Common Stock under
paragraph 2C above, the following will be applicable:

                           (i)      Issuance of Stock  Equivalents.  If the
Company in any manner grants or issues Stock Equivalents (other than other
warrants issued on or about the date hereof contemplated by the Purchase
Agreement and the lowest price per share of Common Stock for which any one share
of Common Stock of the Company or analogous economic right is issuable upon the
exercise of any such Stock Equivalent is less than the Fair Market Value at the
time of the granting or issuing of such Stock Equivalent, then such shares of
Common Stock will be deemed to have been issued and sold by the Company for such
price per share of Common Stock. For purposes of this paragraph, the "lowest
price per share of Common Stock for which any one share of Common Stock or
analogous economic right is issuable" will be equal to the sum of the lowest
amounts of consideration (if any) received or receivable by the Company with
respect to any one share of Common Stock or analogous economic right upon the
exercise of the Stock Equivalent (whether by conversion, exchange or otherwise)
or other similar indication of the price per share of Common Stock as of the
time of granting (such as the floor value for stock appreciation rights). No
further adjustment of the Exercise Shares will be made upon the actual issue of
such, shares of Common Stock or upon the exercise of any rights under the Stock
Equivalents.

                           (ii)     Change in Option Price or Conversion  Rate.
If the purchase price provided for in any Stock Equivalent, the additional
consideration, if any, payable upon the issue, conversion or exchange of any
Stock Equivalent, or the rate at which any Stock Equivalent is convertible into
or exchangeable for shares of Common Stock changes at any time, the Exercise
Shares in effect at the time of such change will be readjusted to

                                      -4-
<PAGE>

the Exercise Shares which would have been in effect at such time had such Stock
Equivalent still outstanding provided for such changed purchase price,
additional consideration or changed conversion rate, as the case inay be, at the
time initially granted, issued or sold; provided that if such adjustment would
result in a decrease in the Exercise Shares then in effect, such adjustment will
not be effective until thirty (30) days after written notice thereof has been
given by the Company to all holders of this Warrant.

                           (iii)    Treatment of Expired and  Unexercised
Stock Equivalents. Upon the expiration of any Stock Equivalent or the
termination of any right to convert or exchange any Stock Equivalent without the
exercise of such Stock Equivalent, the Exercise Shares then in effect will be
adjusted to the Exercise Shares which would have been in effect at the time of
such expiration or termination had such Stock Equivalent, to the extent
outstanding immediately prior to such expiration or termination, never been
issued, provided that if such expiration or termination would result in a
decrease in the Exercise Shares then in effect, such decrease shall not be
effective until thirty (30) days after written notice thereof has been given to
all holders of this Warrant.

                           (iv)     Calculation of Consideration  Received.  If
any shares of Common Stock or Stock Equivalents are issued or sold or deemed to
have been issued or sold for cash, the consideration received therefor will be
deemed to be the net amount received by the Company. In case any shares of
Common Stock or Stock Equivalents are issued or sold for a consideration. other
than cash, the amount of the consideration other than cash received by the
Company will be the Fair Market Value of such consideration. In case any shares
of Common Stock or Stock Equivalents are issued to the owners of the
non-surviving entity in connection with any merger in which the Company is the
surviving entity, the amount of consideration therefor will be deemed to be the
Fair Market Value of such portion of the net assets and business of the
non-surviving entity as is attributable to such shares of Common Stock or Stock
Equivalents, as the case may be.

                           (v)      Integrated  Transactions.  In case any
Stock Equivalent is issued in connection with the issue or sale of other
securities of the Company, together comprising one integrated transaction in
which no specific consideration is allocated to such Stock Equivalent by the
parties thereto, the Stock Equivalent will be deemed to have been issued without
consideration.

                           (vi)     Record Date.  If the Company  takes a
record of the holders of Common Stock for the purpose of entitling them (A) to
receive a dividend or other distribution payable in Common Stock, or Stock
Equivalents or (B) to subscribe for or purchase Common Stock or Stock
Equivalents, then such record date will be deemed to be the date of the issue or
sale of the shares of Common Stock deemed to have been issued or sold upon the
declaration of such dividend or the making of such other distribution or the
date of the granting of such night of subscription or purchase, as the case may
be.

                   2E. Certain Events. If any event occurs of the type
contemplated by the provisions of this Section 2 but not expressly provided for
by such provisions (including, without limitation, the granting of stock
appreciation rights, phantom stock rights or other rights with equity features),
then the Company's board of directors shall in good faith make such adjustments
in the Exercise Price and the number of shares of Common Stock issuable upon
exercise of this Warrant so as to protect the rights of the holders of the
Warrant; provided, that no such adjustment will increase the Exercise Price or
decrease the number of shares of Common Stock obtainable as otherwise determined
pursuant to this Section 2.

                                      -5-
<PAGE>

                  2F. Notices.

                  (i) Immediately upon any adjustment of the terms of this
Warrant under this Section 2, the Company shall give written notice thereof to
the Registered Holder, setting forth the details of such event and the number of
shares of Common Stock or other securities or property thereafter purchasable
upon exercise of this Warrant.

                  (ii) The Company shall give written notice to the Registered
Holder at least 20 days prior to the date on which the Company closes its books
or takes a record (a) with respect to any dividend or distribution upon the
Common Stock, (b) with respect to any pro rata subscription offer to holders of
Common Stock or (c) for determining rights to vote with respect to any Organic
Change, dissolution or liquidation.

                  (iii) The Company will also give written notice to the
Registered Holder at least 20 days prior to the date on which any Organic
Change, dissolution or liquidation shall take place.

         Section 3. Liquidating Dividends. If this Warrant is then exercisable
but has not yet been exercised and the Company declares or pays a dividend upon
the Common Stock payable otherwise than in cash out of earnings or earned
surplus (determined in accordance with generally accepted accounting principles,
consistently applied) in connection with a liquidation of the Company (other
than a stock dividend payable in shares of Common Stock) (a "Liquidating
Dividend"), then the Company will pay to the Registered Holder of this Warrant
at the time of payment thereof the Liquidating Dividend which would have been
paid to such Registered Holder on the Common Stock had this Warrant been fully
exercised immediately prior to the date on which a record is taken for such
Liquidating Dividend, or, if no record is taken, the date as of which the record
holders of Common Stock entitled to such dividends are to be determined.

         Section 4. Purchase Rights. If at any time the Company grants, issues
or sells any options, convertible securities or rights to purchase stock,
warrants, securities or other property pro rata to the record holders of any
class of Common Stock (the "Purchase Rights"), then the Registered Holder of
this Warrant will be entitled to acquire, at a price and upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which such
holder could have acquired if such holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant immediately prior
to the date on which a record is taken for the grant, issuance or sale of such
Purchase Rights (and in no event less than the number of Exercise Shares as
adjusted hereunder as of any such date), or, if no such record is taken, the
date as of which the record holders of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights. Nothing in this Section 4 shall
permit the Company to grant, issue or sell any Purchase Rights without the prior
written consent of the Registered Holder.

         Section 5.        [Reserved]

         Section 6.         Definitions.  As used herein, the following terms
have meanings set forth below:

                  "Appraised Value" shall mean the value of such securities or
property as determined for purposes of this Agreement by a recognized appraisal
or investment banking firm mutually agreeable to the Registered Holder and the
Company.

                  "Common Stock" means the common stock, par value $0.01 per
share, of the Company and, except for purposes of the Common Stock obtainable
upon exercise of this Warrant, any capital stock of any class of the Company
hereafter authorized which is not limited to a fixed sum or percentage of par or
stated value in

                                      -6-
<PAGE>

respect to the rights of the holders thereof to participate in dividends or in
the distribution of assets upon any liquidation, dissolution or winding up of
the Company.

                  "Current Market Value" per share of Common Stock on any date
herein specified shall be deemed to be the amount equal to: (i) if there shall
then be a public market for the Common Stock the average of the daily market
prices for shares of Common Stock for 30 consecutive business days (commencing
30 business days before such date), or if there shall have been a public market
for fewer than 30 business days, the average of the daily market prices for the
actual number of business days (with the "market price," for each such business
day being the last sale price on such day on the New York Stock Exchange, or, if
the Common Stock is not then listed or admitted to trading on the New York Stock
Exchange, on such other principal stock exchange on which such stock is then
listed or admitted to trading or, if no sale takes place on such day on any such
exchange, the average of the closing bid and asked prices on such day as
officially quoted on any such exchange, or, if the Common Stock is not then
listed or admitted to trading on any stock exchange, the market price for each
such business day shall be the last sale price on such day as reported in the
National Association of Securities Dealers, Inc. Automated Quotations System, or
if the Common Stock is not on the National Market List, the average of the
closing reported bid and asked prices on such day in the over-the-counter
market, as furnished by the National Quotation Bureau, Inc., or, if such firm at
the time is not engaged in the business of reporting such prices, as furnished
by any similar firm then engaged in such business and selected by the Company
or, if there is no such firm, as furnished by any member of the National
Association of Securities Dealers, Inc., selected by the Company); or (ii) if
there shall then be no public market for the Fair Market Value.

                  "Fair Market Value" shall mean, as to all securities not
regularly traded in the securities markets and other property, the fair market
value of such securities or property as determined in good faith by the Board of
Directors of the Company at such time; provided, however, that, at the election
of the Registered Holder, the Fair Market Value of such securities and other
property will be the Appraised Value.

                  "Fully Diluted Basis" means, at any given time, the number of
shares of Common Stock actually outstanding at such time, plus the number of
Share Equivalents then outstanding (including under this Warrant), regardless of
their exercise price or its equivalent.

                  "Loan Agreement" means that certain Loan and Security
Agreement dated on or about the date hereof between the Company and Standard
Federal Bank National Association, acting by and through LaSalle Business
Credit, Inc., as its agent and any successor or assign of either or both of
them.

                  "Stock Equivalents" means any option, warrant, right or
similar security or claim exercisable into, exchangeable for, or convertible to
shares of Common Stock or the economic equivalent value of shares of Common
Stock (including, by way of illustration, stock appreciation rights).

                  "Warrants" means this Warrant and all warrants representing
portions of the rights under this Agreement.

         Section 7. No Voting Rights; Limitations of Liability. This Warrant
will not entitle the holder hereof to any voting rights or other rights as a
stockholder of the Company. No provision hereof, in the absence of affirmative
action by the Registered Holder to purchase Common Stock, and no enumeration
herein of the rights or privileges of the Registered Holder shall give rise to
any liability of such holder for the Exercise Price of Common Stock acquirable
by exercise hereof or as a stockholder of the Company.

                                      -7-
<PAGE>

         Section 8. Warrant Transferability. Subject to the transfer conditions
referred to in the legend endorsed hereon, this Warrant and all rights hereunder
are transferable, in whole or in part, without charge to the Registered Holder,
upon surrender of this Warrant with a properly executed Assignment (in the form
of Exhibit B hereto) at the principal office of the Company.

         Section 9. Warrant Exchangeable for Different Denominations. This
Warrant is exchangeable, upon the surrender hereof by the Registered Holder at
the principal office of the Company, for new Warrants of like tenor representing
in the aggregate the purchase rights hereunder, and each of such new Warrants
will represent such portion of such rights as is designated by the Registered
Holder at the time of such surrender. The date the Company initially issues this
Warrant will be deemed to be the "Date of Issuance" hereof regardless of the
number of times new certificates representing the unexpired and unexercised
rights formerly represented by this Warrant shall be issued.

         Section 10. Replacement. Upon receipt of evidence reasonably
satisfactory to the Company (an affidavit of the Registered Holder will be
satisfactory) of the ownership and the loss, theft, destruction or mutilation of
any certificate evidencing this Warrant, and in the case of any such loss, theft
or destruction, upon receipt of indemnity reasonably satisfactory to the Company
(provided that if the holder is a financial institution or other institutional
investor its own agreement will be satisfactory), or, in the case of any such
mutilation upon surrender of such certificate, the Company will (at its expense)
execute and deliver in lieu of such certificate a new certificate of like kind
representing the same rights represented by such lost, stolen, destroyed or
mutilated certificate and dated the date of such lost, stolen, destroyed or
mutilated certificate.

         Section 11. Notices. Except as otherwise expressly provided herein, all
notices referred to in this Warrant will be in writing and will be delivered
personally, sent by reputable express courier service (charges prepaid) or sent
by registered or certified mail, return receipt requested, postage prepaid and
will be deemed to have been given when so delivered, sent or deposited in the
U.S. Mail (i) to the Company, at its principal executive offices and (ii) to the
Registered Holder of this Warrant, at such address designated by the Registered
Holder in writing.

         Section 12. Amendment and Waiver. Except as otherwise provided herein,
the provisions of this Warrant may not be amended and the Company may not take
any action herein prohibited, or omit to perform any act herein required to be
performed by it, without the prior written consent of the Registered Holder.

         Section 13. Descriptive Headings; Governing Law. The descriptive
headings of the several Sections and paragraphs of this Warrant are inserted for
convenience only and do not constitute a part of this Warrant. The construction,
validity and interpretation of this Warrant will be governed by the internal
law, and not the conflicts law, of the State of Georgia.

         Section 14. FORUM SELECTION AND CONSENT TO JURISDICTION. ANY LITIGATION
BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH THIS WARRANT,
SHALL BE BROUGHT AND MAINTAINED EXCLUSIVELY IN THE COURTS OF THE STATE OF
GEORGIA OR IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF
GEORGIA. EACH OF THE PARTIES HEREBY EXPRESSLY AND IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE COURTS OF THE STATE OF GEORGIA AND OF THE UNITED STATES
DISTRICT COURT FOR THE NORTHERN DISTRICT OF GEORGIA FOR THE PURPOSE OF ANY SUCH
LITIGATION AS SET FORTH ABOVE. EACH OF THE PARTIES HEREBY EXPRESSLY AND
IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY

                                      -8-
<PAGE>

OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH
LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY
SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed
and attested by its duly authorized officers under its corporate seal and to be
dated the Date of Issuance hereof.

ATTEST:                                 HORIZON MEDICAL PRODUCTS, INC.

By: /s/ Julie F. Lancaster              By: /s/ William E. Peterson, Jr.
   ------------------------------          -----------------------------------

Title: Vice President, Finance          Title: President
      ---------------------------             --------------------------------

         [CORPORATE SEAL]

                                      -9-
<PAGE>

                                    EXHIBIT A

                               EXERCISE AGREEMENT

To:  HORIZON MEDICAL PRODUCTS, INC.                      Dated:_______________

         The undersigned, pursuant to the provisions set forth in the attached
Warrant (Certificate No. W-____), hereby agrees to subscribe for the purchase of
______ shares of the Common Stock covered by such Warrant and makes payment
herewith in full therefor at the price per share provided by such Warrant.

                                    ____ Net Issue Exercise

                                           Signature:

                                           ------------------------------

                                           Address:
                                                   ----------------------

                                                   ----------------------

<PAGE>

                                    EXHIBIT B

                                   ASSIGNMENT

         FOR VALUE RECEIVED, __________________________ hereby sells, assigns
and transfers all of the rights of the undersigned under the attached Warrant
(Certificate No. W-_____) with respect to the number of shares of the Common
Stock covered thereby set forth below, unto:

         Names of Assignee                  Address           No. of Shares

                                        Signature:
                                                  ------------------------------

                                        Witness:
                                                --------------------------------<PAGE>
                                                                   EXHIBIT 10.65

                              EMPLOYMENT AGREEMENT

         THIS EMPLOYMENT AGREEMENT ("Agreement") is made and entered into as of
March 16, 2002, by and between Marshall B. Hunt, an individual resident of the
State of Florida ("Employee"), and Horizon Medical Products, Inc., a Georgia
corporation (the "Employer").

                              W I T N E S S E T H:

         WHEREAS, Employee and Employer desire to enter into a new Employment
Agreement that replaces and supersedes in its entirety the Employment Agreement
dated April 3, 1998 between Employee and Employer, as amended;

         NOW, THEREFORE, in consideration of the premises and the mutual
promises and agreements contained herein, the parties hereto, intending to be
legally bound, hereby agree as follows:

         Section 1. Employment.

         Subject to the terms hereof, the Employer hereby employs Employee, and
Employee hereby accepts such employment. Employee will serve as Chairman of the
Board of Directors and Chief Executive Officer of Employer. Employee agrees to
devote his full business time and best efforts to the performance of the duties
that the Board of Directors of Employer (the "Board of Directors") may assign
Employee from time to time.

         Section 2. Term of Employment.

         The term of Employee's employment hereunder (the "Term") shall be from
March 16, 2002 (the "Effective Date") until the earlier of (i) March 16, 2003 or
(ii) the occurrence of any of the following events:

                  (a) The death or total disability of Employee (total
disability meaning the failure to fully perform his normal required services
hereunder for a period of ) three (3) consecutive months during the Term hereof,
as determined by the Board of Directors, by reason of mental or physical
disability);

                  (b) The termination by Employer of Employee's employment
hereunder, upon prior written notice to Employee, for "good cause", as
determined by the Board of Directors. For purposes of this Agreement, "good
cause" for termination of Employee's employment shall exist (i) if Employee is
convicted of, pleads guilty to, or confesses to any felony or any act of fraud,
misappropriation, or embezzlement, (ii) if Employee has engaged in a dishonest
act to the material damage or prejudice of Employer or a subsidiary of Employer,
or in conduct or activities materially damaging to the business of Employer or a
subsidiary of Employer, (iii) if Employee fails to comply with the terms of this
Agreement, and, within thirty (30) days after written notice from Employer of
such failure, Employee has not corrected such

<PAGE>

failure or, having once received such notice of failure and having so corrected
such failure, Employee at any time thereafter again so fails, or (iv) if
Employee fails to follow a lawful directive of the Board of Directors (which is
consistent with Employee's position as Chairman of the Board and Chief Executive
Officer) and, within thirty (30) days after written notice from Employer of such
failure, Employee has not corrected such failure; or

                  (c) The termination of this Agreement by either party upon at
least ninety (90) days prior written notice.

         Section 3. Compensation.

         3.1 Term of Employment. Employer will provide Employee with the
following salary, expense reimbursement, and additional employee benefits during
the term of employment hereunder:

                  (a) Salary. Employee will be paid a salary (the "Salary") of
no less than Two Hundred and Seventy Thousand Dollars ($270,000) per annum, less
deductions and withholdings required by applicable law. The Salary shall be paid
to Employee in equal monthly installments (or on such more frequent basis as
other executives of Employer are compensated).

                  (b) Bonus.

                           (i) Employee will be entitled to annual bonus (the
         "Bonus") equal to 50% of his Salary for the entire 2002 fiscal year,
         based upon the achievement during the 2002 fiscal year of Employer
         measured at the end of such year of a 25% or more (but less than 35%)
         increase in the earnings per share of the Common Stock from the
         earnings per share of the Common Stock for the 2001 fiscal year. If
         such increase in earnings per share is 35% or more, then the Bonus for
         such year shall equal 100% of Employee's Salary for the entire 2002
         fiscal year. Any Bonus earned shall be paid promptly upon the
         availability of annual financial results for 2002 (which is expected to
         occur in February 2003). Employee shall also be entitled to receive a
         pro rated Bonus, calculated based on the formula set forth above, for
         the period commencing January 1, 2003 and terminating on March 31, 2003
         based upon the achievement during such period of an earnings per share
         increase of either 25% or 35%, as described above, when compared with
         the same period during 2002. Such Bonus for 2003, if any, shall be
         payable May 1, 2003. In the calculation of such Bonus under this
         Section 3.1(b)(i), all restructuring costs and charges incurred by
         Employer in connection with the refinancing in March 2002 will be
         disregarded.

                           (ii) Employee will be entitled, at any time, whether
         employed by the Company or not, to an additional Bonus in an amount
         equal to one percent (1%) of the principal amount of any Purchaser
         Senior Subordinated Convertible Note issued to ComVest Venture
         Partners, L.P. and any Additional Note (as defined in the Note

                                      -2-
<PAGE>

         Purchase Agreement) issued to the Additional Note Purchasers upon and
         to the extent any such Note is paid or converted, payable upon such
         payment or conversion.

                  (c) Car Allowance. Employer shall provide Employee with a
leased automobile during the Term of this Agreement, the monthly lease payments
for which shall not exceed $1,500.00, and shall pay for gasoline, insurance, and
maintenance expenses for such automobile.

                  (d) Club Dues. Employee shall be reimbursed for the initiation
fee and monthly dues (not in excess of the initiation fee and monthly dues of
the Capital City Club) for any one club joined by Employee during the Term.
Employee shall be reimbursed for the dues and expenses incurred by Employee and
his family in connection with his membership in the Young Presidents
Organization.

                  (e) Vacation. Employee shall receive eight (8) weeks vacation
time per calendar year during the term of this Agreement. Any unused vacation
days in any calendar year may not be carried over to subsequent years.

                  (f) Expenses. Employer shall reimburse Employee for all
reasonable and necessary expenses incurred by Employee in furtherance of the
Company's business at the request of and on behalf of Employer.

                  (g) Benefit Plan. Employee may participate in such medical,
dental, disability, hospitalization, life insurance, and other benefit plans
(such as pension and profit sharing plans) as Employer maintains from time to
time for the benefit of other executives of Employer, on the terms and subject
to the conditions set forth in such plans. Without limiting the foregoing,
Employer shall pay the premiums on the disability policies maintained on
Employee's behalf and set forth on Exhibit "A" hereto. Employer shall also
reimburse Employee with respect to any reasonable medical and dental expenses
incurred by Employee and/or his immediate family members which are not
reimbursable under the medical and dental benefit plans maintained by Employer
in which Employee participates.

                  3.2 Effect of Termination or Change of Control.

                  (a) Except as hereinafter provided, upon the termination of
the employment of Employee hereunder for any reason, Employee shall be entitled
to all compensation and benefits earned or accrued under Section 3.1 as of the
effective date of termination (the "Termination Date"), but from and after the
Termination Date no additional compensation or benefits shall be earned by
Employee hereunder. Except in the case of a termination of the employment of
Employee pursuant to Section 2(b) hereof or a termination by Employee of
Employee's employment pursuant to Section 2(c) hereof, Employee shall be deemed
to have earned any Bonus payable with respect to the calendar year in which the
Termination Date occurs on a prorated basis (with the Bonus calculated as of the
end of the month in which termination occurs). Any such Bonus shall be payable
on (i) the date on which the Bonus would

                                      -3-
<PAGE>

have been paid had Employee continued his employment hereunder if the
Termination Date occurs during December or (ii) the 30th day following the end
of the month in which the Termination Date occurs and shall be calculated as of
the end of the month in which the Terminate Date occurs. If Employee's
employment hereunder is terminated by Employer pursuant to Section 2(c) hereof,
or if Employee is not offered employment with Employer commencing March 16, 2003
on terms and conditions that are at least as favorable as the terms and
conditions of this Agreement, or if Employee continues his employment with
Employer after March 16, 2003 and such employment is then terminated at any time
by Employer for any reason other than good cause (as defined in Section 2(b)
above), then, in any such event in addition to any other amount payable
hereunder, Employer shall continue to pay Employee his normal Salary pursuant to
Section 3.1(a) for twelve (12) months after the Termination Date, plus an amount
equal to Employee's Bonus for the twelve (12) months immediately prior to the
Termination Date, in periodic payments on the dates each month on which
Employer's employees are paid. Employee shall continue to be eligible to receive
the benefits set forth in Section 3.1(c) and Section 3.1(g) above during such
twelve (12) months.

                  (b) Upon the occurrence of a Change in Control Event (as
defined below) and if at the time of the Change in Control Event Employee is
employed with Employer or is receiving severance payments under Section 3.2(a)
above, then Employer will pay to Employee (in lieu of an obligation to make
further payments to Employee under or on account of Section 3.1(a)) the annual
Salary that would have been payable to Employee under this Agreement for each of
the three (3) years after the Change in Control Event. The amounts payable to
Employee under the previous sentence of this Section 3.2(b) shall be paid by
Employer in equal monthly payments during such period or in a lump sum, at the
option of Employee.

                           If any payment or other benefit (a "Termination
Payment") received or to be received by Employee in connection with a Change in
Control Event (whether or not this Agreement is terminated) or Employee's
termination of employment (whether pursuant to the terms of this Agreement or
any other plan, arrangement, or agreement with Employer, with any person whose
actions result in a Change in Control Event or with any person affiliated with
Employer or such person) is or will be subject to the tax (the "Excise Tax")
imposed by ss.4999 of the Internal Revenue Code of 1986, as amended (the
"Code"), Employer shall pay to Employee a Gross-Up Payment (as defined below) to
the extent provided by the third paragraph of this Section 3.2(b). A Gross-Up
Payment shall be payable pursuant to this Section 3.2(b) on and subject to the
following terms and conditions:

                           (i) At the time the applicable Termination Payment is
         made, an additional amount (the "Gross-Up Payment") shall be paid by
         Employer such that the net amount retained by Employee, after deduction
         of any Excise Tax on such Termination Payment and any federal, state,
         and local income tax, employment tax, and Excise Tax on the Gross-Up
         Payment, shall be equal to the amount or value of such Termination
         Payment. For purposes of determining whether any such Termination
         Payment will be subject to the Excise Tax, all Termination Payments
         shall be treated as "parachute payments" within the meaning
         ofss.280G(b)(2) of the Code, and all "excess parachute

                                      -4-
<PAGE>

         payments" within the meaning of ss.280G(b)(1) of the Code shall be
         treated as being subject to the Excise Tax, unless in the opinion of
         tax counsel reasonably acceptable to Employee and selected by the
         accounting firm which, immediately prior to the Change in Control
         Event, was Employer's independent auditors, such payments (in whole or
         in part) do not constitute "parachute payments" within the meaning of
         ss.280G of the Code or represent reasonable compensation for services
         actually rendered in excess of the "base amount" allocable to such
         reasonable compensation. The full amount of the Gross-Up Payment shall
         be treated as being subject to the Excise Tax. The value of any
         non-cash benefits or any deferred payment or benefit shall be
         determined in accordance with the principles of ss.ss.280G(d)(3) and
         (4) of the Code.

                           (ii) For purposes of determining the amount of any
         Gross-Up Payment, Employee shall be deemed to pay federal income taxes
         at the highest marginal rate of federal income taxation in the calendar
         year in which the applicable Termination Payment or Gross-Up Payment is
         made, and shall be deemed to pay state and local income taxes at the
         highest marginal rates of taxation in the state and locality of his
         residence on the date the applicable Termination Payment or Gross-Up
         Payment is made, net of the maximum reduction in federal income taxes
         that could be obtained from deduction of such state and local taxes.

                           (iii) If the Excise Tax or income tax payable with
         respect to a Gross-Up Payment as finally determined exceeds the amount
         taken into account or paid to Employee at the time the applicable
         Termination Payment or Gross-Up Payment is made (including by reason of
         any payment the existence or amount of which cannot be determined at
         the time of the applicable Gross-Up Payment), Employer shall make an
         additional Gross-Up Payment in respect of such excess (plus any
         interest payable by Employee with respect to such excess) at the time
         that the amount of such excess if finally determined.

                           For purposes of this Agreement a "Change in Control
Event" shall mean the occurrence of either one of the following transactions on
or prior to March 16, 2005:

                  (1) the adoption of a plan of merger or consolidation of
         Employer with any other corporation as a result of which the holders of
         the outstanding voting stock of Employer as a group would receive less
         than 50% of the voting stock of the surviving or resulting corporation;
         or

                  (2) the sale of substantially all of the assets of Employer,
         and

                  (3) as a result of the transaction described in clause (1) or
         (2) above, the shareholders of Employer receive cash and/or securities
         valued on the date of the consummation of the transaction at $3.00 or
         more per share.

                                      -5-
<PAGE>

         Section 4. Other Payments and Reimbursements.

         In consideration for Employee's entering into this Agreement, Employer
shall:

                  (a) pay to Employee at the closing of the Transaction (defined
below) the salary of Employee during the period of October 16, 2001 through the
date of such payment (at the salary rate in effect during such period), which
salary was not previously paid to Employee pursuant to the provisions of the
Forbearance Agreement (as defined below); (b) reimburse Employee at the closing
of the Transaction for all funds advanced personally by Employee on behalf of
Employer during Employee's efforts in 2002 to refinance its senior secured
indebtedness;

                  (c) pay to Employee within one week after the closing of the
Transaction bonus compensation in the amount of $319,921.43, with which payment
Employee shall immediately repay to Employer all principal and accrued interest
under outstanding promissory notes payable by Employee to Employer;

                  (d) grant options to purchase the common shares of Employer
pursuant to the provisions of that certain Option Agreements dated March 16,
2002; and

                  (e) issue to Employee 75,000 shares of Employer's common stock
in consideration for Employee's funding personally one-half of the principal
amount of the Convertible Promissory Bridge Note dated March 16, 2002.

         Except as otherwise provided above in this Section 4, Employee hereby
forever waives and relinquishes any right or interest that Employee may have or
claim to have with respect to all Salary compensation, bonus compensation, or
any other compensation or benefits accruing prior to the date hereof under
Employee's prior Employment Agreement dated April 3, 1998, as amended, between
Employer and Employee.

         For purposes of this Section 4:

                           (i) the term "Transaction" shall mean the refinancing
         of the senior secured indebtedness of Employer in a financing described
         under that certain Note Purchase Agreement dated March 1, 2002 (the
         "Note Purchase Agreement"); and

                           (ii) the term "Forbearance Agreement" shall mean that
         certain Forbearance Agreement dated March 30, 2001 between Employer and
         Bank of America, N.A., as amended.

         Section 5. Miscellaneous.

         5.1 Severability. The covenants in this Agreement shall be construed as
covenants independent of one another and as obligations distinct from any other
contract between

                                      -6-
<PAGE>

Employee and Employer. Any claim that Employee may have against Employer shall
not constitute a defense to enforcement by Employer of this Agreement.

         5.2 Notices. Any notice or other document to be given hereunder by any
party hereto to any other party hereto shall be in writing and delivered in
person or by courier, by telecopy transmission, or sent by any express mail
service, postage or fees prepaid to the following addresses:

                  Employer:         Attention:  President
                                    Seven North Parkway Square
                                    4200 Northside Parkway, N.W.
                                    Atlanta, Georgia  30327

                  Employee:         Mr. Marshall B. Hunt
                                    3935 Paces Manor
                                    Atlanta, Georgia  30339

or at such other address or number for a party as shall be specified by like
notice. Any notice which is delivered in the manner provided herein shall be
deemed to have been duly given to the party to whom it is directed upon actual
receipt by such party or its agent.

         5.3 Binding Effect. This Agreement inures to the benefit of, and is
binding upon, Employer and its respective successors and assigns, and Employee,
together with Employee's executor, administrator, personal representatives,
heirs, and legatees.

         5.4 Entire Agreement. This Agreement is intended by the parties hereto
to be the final expression of their agreement with respect to the subject matter
hereof and is the complete and exclusive statement of the terms thereof,
notwithstanding any representations, statements, or agreements to the contrary
heretofore made. This Agreement supersedes and terminates all prior employment
and compensation agreements, arrangements, and understandings between or among
Employer and Employee. This Agreement may be modified only by a written
instrument signed by all of the parties hereto.

         5.5 Governing Law. This Agreement shall be deemed to be made in, and in
all respects shall be interpreted, construed, and governed by and in accordance
with, the laws of the State of Georgia without reference to its conflicts of law
principles. No provision of this Agreement shall be construed against or
interpreted to the disadvantage of any party hereto by any court or other
governmental or judicial authority or by any board of arbitrators by reason of
such party or its counsel having or being deemed to have structured or drafted
such provision.

         5.6 Headings. The section and paragraph headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.

                                      -7-
<PAGE>

         5.7 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same instrument.

                                      -8-
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the date first above written.

                                    HORIZON MEDICAL PRODUCTS, INC.

                                    By /s/ William E. Peterson, Jr.
                                      ------------------------------------
                                      William E. Peterson, Jr., President

                                    EMPLOYEE:

                                    /s/ Marshall B. Hunt
                                    --------------------------------------
                                    Marshall B. Hunt

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00038-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00038-of-00352.parquet"}]]